Pharmaceutical Substances Syntheses, Patents, Applications - Part 217

Pharmaceutical Substances Syntheses, Patents, Applications - Part 217. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers. | Venlafaxine V 2161 N N-dimethyl-4-methoxyphenylthioacetamide 1. 2. I N N-dimethyl-a- 1 -hydroxycyclohexyl -4-methoxyphenyl -thioacetamide III H2 Raney-Ni m ------------------ Venlafaxine Reference s a EP 112 669 American Home Products USA-prior. . b GB 2 227 743 Wyeth Brother Ltd GB-prior. . combination with opioid antagonists WO 9 609 047 Du Pont Merck Pharm. Co. USA-prior. . combination with -blockers EP687 472 Eli Lilly Co. USA-prior. . controlled release formulation WO 9 427 589 Alza Corp. USA-prior. . Formulation s tabl. 25 mg mg 50 mg 75 mg 100 mg as hydrochloride Trade Namelsj D Trevilor Wyeth GB Efexor Wyeth I Efexor Wyeth-Lederle USA Effexor Wyeth-Ayerst 2162 V Verapamil Verapamil Iproveratril ATC C08DA01 Use coronary vasodilator RN 52-53-9 MF C27H3 iN2O4 MW EINECS 200-145-1 LD50 1520 pg kg M . 130 mg kg M . 7250 pg kg R . 163 mg kg R . CN ct- 3- 2- 3 4-dimethoxyphenyl ethyl methylamino propyl -3 4-dimethoxy-ct- l-methylethyl benzeneacetonitrile monohydrochloride RN 152-11-4 MF C27H38N2O4 HCl MW EINECS 205-800-5 LD5o 5795 pg kg M . 163 mg kg M . 16 mg kg R . 108 mg kg R . 400 mg kg dog . CN o-ch3 o-ch3 H-jCs C ch3 NoNH2 2- 3 4-dimethoxyphenyl - 3- methylbutyro nitrile 1 isopropyl chloride 1 -bromo-3-chloropropone H3C y H3C ch3 . II HX 0. 11 H3c ch3 N- 2- 3 4-dimethoxy- phenyl ethyl methylamine Reference s DE 1 154 810 Knoll appl. . DE 1 158 083 Knoll appl. . US 3 261 859 Knoll D-prior. . alternative synthesis DAS 2 263 527 Teikoku Hormaone Mfg. appl. J-prior. . DAS 2 631 222 Knoll appl. . US 4 115 432 Knoll D-prior. . - -verapamil DAS 2 059 923 Knoll appl. . Formulation s amp. 5 mg 2 ml drg. 40 mg 80 mg 120 mg f. c. tabl. 40 mg 80 mg 120 mg s. r. cps. 120 mg 180 mg 240 mg s. r. .

Không thể tạo bản xem trước, hãy bấm tải xuống
TÀI LIỆU MỚI ĐĂNG
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.